Beam Therapeutics Inc. (BEAM) Profit Margin
Beam Therapeutics Inc. (BEAM) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2020-12-31 | -810800.00% |
| 2021-12-31 | -714.91% |
| 2022-12-31 | -474.54% |
| 2023-12-31 | -35.09% |
| 2024-12-31 | -593.13% |
| 2025-12-31 | -57.24% |
How BEAM compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| ACHV | Achieve Life Sciences Inc. | -24.38% |
| ARVN | Arvinas Inc. | -30.77% |
| NMTC | NeuroOne Medical Technologies Corporation | -39.63% |
| RARE | Ultragenyx Pharmaceutical Inc. | -85.44% |
| VNDA | Vanda Pharmaceuticals Inc. | -102.02% |
These are five companies in the same sector as BEAM with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Beam Therapeutics Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("BEAM", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | BEAM | $26.57 | -1.96% | 1.19M |
| 3 | ||||
| 4 | ||||
| 5 |